Stride Ventures, a leading venture capital firm from India, announced the successful close of Stride Ventures India Fund III for $165 million, achieved within just a year of the first close of the third fund in 2023. This third fund has received strong support from a diverse mix of investors, including insurance companies, family offices, corporate treasuries and high net worth individuals (HNIs).
Fund III’s portfolio includes top companies such as BlueStone, Moneyview, Moove, Foxtale, CureSkin, NewMe, Nat Habit and AgroStar. These portfolio companies represent the fund’s strategic focus on consumer brands, financial services and cleantech sectors, and underscore Stride Ventures’ commitment to backing high-growth, breakthrough entrepreneurs leading the market.
“We are broadening our impact in the Indian startup ecosystem, with comprehensive financial solutions for working capital, capital investments, inorganic expansion and growth,” said Apoorva Sharma, Managing Partner, Stride Ventures.
Stride Ventures has a portfolio of more than 140 startups across consumer, fintech, agri-tech, B2B commerce, health tech, B2B SaaS, mobility and energy (EV) solutions.
“As we close Fund III, our vision extends beyond the immediate market horizon,” said Ishpreet Singh Gandhi, Founder and Managing Partner at Stride Ventures. “We remain committed to supporting visionary founders.”
Stride Ventures said it has successfully returned its entire Fund I, delivering excellent returns in the sector. A few months ago, Stride Ventures also published the third edition of the ‘India Venture Debt Report- 2024.’ This report highlights evolving use cases and highlights a growing interest in CleanTech investments and integrated debt solutions within the Indian venture capital debt ecosystem.
First print: May 02, 2024 | 12:59 pm IST